OneDigital Investment Advisors LLC Purchases Shares of 258,561 Privia Health Group, Inc. $PRVA

OneDigital Investment Advisors LLC acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 2nd quarter, Holdings Channel.com reports. The firm acquired 258,561 shares of the company’s stock, valued at approximately $6,653,000.

A number of other institutional investors also recently made changes to their positions in PRVA. Bank of New York Mellon Corp bought a new position in shares of Privia Health Group during the second quarter worth approximately $74,425,000. ArrowMark Colorado Holdings LLC lifted its holdings in Privia Health Group by 139.4% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 841,266 shares of the company’s stock valued at $19,946,000 after buying an additional 489,866 shares during the period. Freestone Grove Partners LP grew its holdings in Privia Health Group by 40.6% during the 4th quarter. Freestone Grove Partners LP now owns 1,213,342 shares of the company’s stock worth $28,768,000 after acquiring an additional 350,194 shares during the period. Renaissance Group LLC bought a new stake in shares of Privia Health Group during the 4th quarter valued at about $7,776,000. Finally, Qube Research & Technologies Ltd grew its stake in Privia Health Group by 93.3% during the second quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock worth $14,013,000 after purchasing an additional 294,101 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on PRVA shares. Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Canaccord Genuity Group set a $32.00 target price on Privia Health Group in a research report on Friday, August 7th. Citigroup restated a “buy” rating on shares of Privia Health Group in a report on Thursday, July 23rd. Barclays dropped their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Finally, Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus price target of $31.00.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $22.00 on Monday. The company has a market capitalization of $2.81 billion, a P/E ratio of 104.77, a price-to-earnings-growth ratio of 1.77 and a beta of 0.85. The company’s 50-day moving average is $24.71 and its 200 day moving average is $23.28. Privia Health Group, Inc. has a fifty-two week low of $19.53 and a fifty-two week high of $28.82.

Insider Activity at Privia Health Group

In related news, CFO David Mountcastle sold 21,275 shares of the firm’s stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total value of $588,679.25. Following the completion of the transaction, the chief financial officer directly owned 164,853 shares of the company’s stock, valued at approximately $4,561,482.51. This trade represents a 11.43% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 53,722 shares of the stock in a transaction on Monday, July 6th. The stock was sold at an average price of $27.24, for a total value of $1,463,387.28. Following the sale, the director owned 68,188 shares in the company, valued at approximately $1,857,441.12. This represents a 44.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 327,886 shares of company stock valued at $8,628,256. 5.70% of the stock is currently owned by company insiders.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.